Patents by Inventor Paul Story

Paul Story has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240303907
    Abstract: In examples, the number of rays used to sample lighting conditions of a light source in a virtual environment with respect to particular locations in the virtual environment may be adapted to scene conditions. An additional ray(s) may be used for locations that tend to be associated with visual artifacts in rendered images. A determination may be made on whether to cast an additional ray(s) to a light source for a location and/or a quantity of rays to cast. To make the determination variables such as visibilities and/or hit distances of ray-traced samples of the light source may be analyzed for related locations in the virtual environment, such as those in a region around the location (e.g., within an N-by-N kernel centered at the location). Factors may include variability in visibilities and/or hit distances, differences between visibilities and/or hit distances relative to the location, and magnitudes of hit distances.
    Type: Application
    Filed: May 21, 2024
    Publication date: September 12, 2024
    Inventor: Jonathan Paul Story
  • Patent number: 11995759
    Abstract: In examples, the number of rays used to sample lighting conditions of a light source in a virtual environment with respect to particular locations in the virtual environment may be adapted to scene conditions. An additional ray(s) may be used for locations that tend to be associated with visual artifacts in rendered images. A determination may be made on whether to cast an additional ray(s) to a light source for a location and/or a quantity of rays to cast. To make the determination variables such as visibilities and/or hit distances of ray-traced samples of the light source may be analyzed for related locations in the virtual environment, such as those in a region around the location (e.g., within an N-by-N kernel centered at the location). Factors may include variability in visibilities and/or hit distances, differences between visibilities and/or hit distances relative to the location, and magnitudes of hit distances.
    Type: Grant
    Filed: September 7, 2021
    Date of Patent: May 28, 2024
    Assignee: NVIDIA Corporation
    Inventor: Jonathan Paul Story
  • Publication number: 20220005257
    Abstract: In examples, the number of rays used to sample lighting conditions of a light source in a virtual environment with respect to particular locations in the virtual environment may be adapted to scene conditions. An additional ray(s) may be used for locations that tend to be associated with visual artifacts in rendered images. A determination may be made on whether to cast an additional ray(s) to a light source for a location and/or a quantity of rays to cast. To make the determination variables such as visibilities and/or hit distances of ray-traced samples of the light source may be analyzed for related locations in the virtual environment, such as those in a region around the location (e.g., within an N-by-N kernel centered at the location). Factors may include variability in visibilities and/or hit distances, differences between visibilities and/or hit distances relative to the location, and magnitudes of hit distances.
    Type: Application
    Filed: September 7, 2021
    Publication date: January 6, 2022
    Inventor: Jonathan Paul Story
  • Patent number: 11145110
    Abstract: In examples, the number of rays used to sample lighting conditions of a light source in a virtual environment with respect to particular locations in the virtual environment may be adapted to scene conditions. An additional ray(s) may be used for locations that tend to be associated with visual artifacts in rendered images. A determination may be made on whether to cast an additional ray(s) to a light source for a location and/or a quantity of rays to cast. To make the determination variables such as visibilities and/or hit distances of ray-traced samples of the light source may be analyzed for related locations in the virtual environment, such as those in a region around the location (e.g., within an N-by-N kernel centered at the location). Factors may include variability in visibilities and/or hit distances, differences between visibilities and/or hit distances relative to the location, and magnitudes of hit distances.
    Type: Grant
    Filed: March 18, 2020
    Date of Patent: October 12, 2021
    Assignee: NVIDIA Corporation
    Inventor: Jonathan Paul Story
  • Publication number: 20200302675
    Abstract: In examples, the number of rays used to sample lighting conditions of a light source in a virtual environment with respect to particular locations in the virtual environment may be adapted to scene conditions. An additional ray(s) may be used for locations that tend to be associated with visual artifacts in rendered images. A determination may be made on whether to cast an additional ray(s) to a light source for a location and/or a quantity of rays to cast. To make the determination variables such as visibilities and/or hit distances of ray-traced samples of the light source may be analyzed for related locations in the virtual environment, such as those in a region around the location (e.g., within an N-by-N kernel centered at the location). Factors may include variability in visibilities and/or hit distances, differences between visibilities and/or hit distances relative to the location, and magnitudes of hit distances.
    Type: Application
    Filed: March 18, 2020
    Publication date: September 24, 2020
    Inventor: Jonathan Paul Story
  • Patent number: 8501245
    Abstract: Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.
    Type: Grant
    Filed: March 24, 2004
    Date of Patent: August 6, 2013
    Assignee: Morinda, Inc.
    Inventors: Mian Ying Wang, Chen Xing Su, Afa Kehaati Palu, Bing-Nan Zhou, Brett Justin West, Johannes Joseph Westendorf, Claude Jarakae Jensen, Stephen Paul Story
  • Publication number: 20050042053
    Abstract: The present invention is a housing retrofit assembly for a milling machine or the like, including a quick adjusting stop nut for selective sliding coarse adjustment and rotational precision fine adjustment for rotatable engagement with a threaded rod or shaft in close tolerances, which provides stable precision engagement with the shaft, and which provides a positive locking mechanism. A unique lighting assembly is also disclosed which moves with the machine head for illuminating the milling cutter or the workpiece.
    Type: Application
    Filed: September 14, 2004
    Publication date: February 24, 2005
    Inventor: Paul Story
  • Publication number: 20040224038
    Abstract: Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.
    Type: Application
    Filed: March 24, 2004
    Publication date: November 11, 2004
    Inventors: Mian Ying Wang, Chen Xing Su, Afa Kehaati Palu, Bing-Nan Zhou, Brett Justin West, Johannes Joseph Westendorf, Claude Jarakae Jensen, Stephen Paul Story
  • Publication number: 20020090406
    Abstract: A method for treating people with various ailments and diseases by administering an effective amount of processed Morinda citrifolia.
    Type: Application
    Filed: December 4, 2001
    Publication date: July 11, 2002
    Inventors: Chen Xing Su, Claude Jarakae Jensen, Stephen Paul Story